| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.56B | 25.97B | 29.06B | 37.88B | 27.71B | 20.91B |
| Gross Profit | 8.02B | 7.53B | 8.47B | 15.42B | 9.41B | 5.24B |
| EBITDA | 5.61B | 4.21B | 4.88B | 12.78B | 6.58B | 2.89B |
| Net Income | 1.80B | 674.00M | 1.26B | 7.66B | 3.15B | 459.00M |
Balance Sheet | ||||||
| Total Assets | 51.83B | 51.84B | 52.75B | 54.59B | 49.95B | 47.19B |
| Cash, Cash Equivalents and Short-Term Investments | 624.00M | 853.00M | 941.00M | 901.00M | 499.00M | 1.45B |
| Total Debt | 14.18B | 12.81B | 12.57B | 11.93B | 10.85B | 11.36B |
| Total Liabilities | 26.67B | 27.40B | 27.55B | 28.72B | 26.25B | 24.83B |
| Stockholders Equity | 25.12B | 24.41B | 25.16B | 25.82B | 23.65B | 22.36B |
Cash Flow | ||||||
| Free Cash Flow | 2.22B | 1.38B | 2.47B | 5.67B | 2.10B | 1.77B |
| Operating Cash Flow | 4.14B | 3.54B | 5.07B | 8.11B | 3.89B | 3.32B |
| Investing Cash Flow | -1.64B | -2.13B | -2.96B | -2.90B | -1.81B | -1.20B |
| Financing Cash Flow | -2.39B | -1.45B | -2.06B | -4.73B | -3.00B | -1.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | C$39.33B | 15.85 | 7.22% | 3.65% | 2.67% | 154.37% | |
70 Outperform | C$564.25M | 3.19 | 33.41% | ― | 20.52% | 1196.33% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | C$32.96M | ― | -198.96% | ― | 51.04% | -2521.74% | |
50 Neutral | C$67.42M | -6.06 | -37.27% | ― | -36.30% | 10.13% | |
50 Neutral | $20.06M | -4.72 | -60.25% | ― | -19.17% | -3607.69% | |
43 Neutral | C$8.53M | -8.38 | -21.94% | ― | ― | 39.56% |
Nutrien Ltd. reported strong third-quarter 2025 results, with net earnings of $0.5 billion and adjusted EBITDA of $1.4 billion. The company has shown significant earnings growth through increased fertilizer sales and improved operational efficiency. Nutrien is reviewing strategic alternatives for its Phosphate business to enhance long-term value and has completed a controlled shutdown of its Trinidad Nitrogen facility due to operational challenges. Additionally, Nutrien plans to sell its stake in Profertil S.A., aiming to use the proceeds for growth investments, share repurchases, and debt reduction, aligning with its strategic focus on core assets.
Nutrien Ltd. reported strong financial performance for the third quarter of 2025, with net earnings of $0.5 billion and an adjusted EBITDA of $1.4 billion. The company achieved record fertilizer sales volumes and improved reliability, contributing to increased earnings and cash returns to shareholders. Nutrien is reviewing strategic alternatives for its Phosphate business to enhance long-term value and has completed a controlled shutdown of its Trinidad Nitrogen facility due to operational challenges. The company also announced the sale of its equity interest in Profertil S.A., aligning with its capital allocation priorities.
Nutrien Ltd. announced a quarterly dividend of US$0.545 per share, payable on January 16, 2026, to shareholders of record as of December 31, 2025. This announcement reflects Nutrien’s ongoing commitment to providing shareholder value and highlights its robust financial position, which allows it to continue rewarding investors while maintaining its strategic focus on growth and efficiency in the agricultural sector.
Nutrien Ltd. has announced a controlled shutdown of its Trinidad Nitrogen operations due to port access restrictions and unreliable natural gas supply, which have impacted the facility’s financial performance. Despite this, Nutrien expects to meet its 2025 nitrogen sales volume targets, thanks to strong performance from its North American operations, and continues to engage with stakeholders to assess future options.
Nutrien Ltd. announced an agreement to sell its 50 percent equity position in the Argentine nitrogen producer Profertil S.A. to Adecoagro S.A. and Asociacion de Cooperativas Argentinas Coop Ltda for approximately $600 million. This strategic move aligns with Nutrien’s focus on core assets and geographies, with plans to allocate proceeds towards growth investments, share repurchases, and debt reduction, enhancing earnings quality and supporting long-term growth.